Solid-Phase Peptide Condensation with Carbodiimide Additives
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing peptide synthesis methods, particularly those using a membrane as a stationary phase, face challenges with low reaction conversion rates and crystal precipitation during amidation reactions, especially when synthesizing drug-like peptides containing N-alkylamino acids, leading to inefficient and impure peptide production.
Innovation Solution
A method involving the use of specific carbodiimide-based condensing agents and additives in the presence of a carbodiimide-based condensing agent represented by formula (A) to enhance the condensation reaction, allowing for high-purity peptide production by avoiding crystal precipitation and improving reaction conversion rates.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If existing amidation conditions are used for synthesizing drug-like peptides with N-alkylamino acids, then the synthesis can be performed, but the reaction conversion rate is low (3-64%)
Solution Approach 1:
The patent changes the chemical parameters of the amidation reaction by introducing a specific condensing agent system (formula A) with optimized molecular structure and stoichiometric ratios, transforming the reaction from low conversion (3-64%) to high conversion (>90%), thereby resolving the contradiction between productivity and reliability
Solution Approach 2:
The patent employs a specific condensing agent (formula A) as an intermediary substance that facilitates the amidation reaction between carboxylic acid and amino acid, acting as a mediator to achieve high conversion rates without direct harmful interactions, thus improving both productivity and reliability
2Productivity
If reagent concentration is doubled to improve reaction conversion rate, then conversion rate increases, but crystal precipitation occurs causing clogging and impurities
Solution Approach 1:
The patent optimizes the concentration parameters of reagents by establishing a specific ratio relationship between condensing agent and amino acid (1:1 to 1:2), achieving high conversion rates without crystal precipitation, thus resolving the contradiction between productivity and harmful factors
Solution Approach 2:
The patent converts the potential harmful effect of high reagent concentration (which causes crystal precipitation) into a beneficial high conversion rate by precisely controlling the concentration ratio, transforming what would be a harmful condition into an optimized reaction parameter
3Productivity
If automated liquid delivery is employed to speed up synthesis, then efficiency improves, but crystal precipitation causes clogging
Solution Approach 1:
The patent adjusts the concentration and ratio parameters of reagents to be compatible with automated liquid delivery systems, enabling high-efficiency automated synthesis without crystal precipitation-induced clogging, thus resolving the contradiction between productivity and ease of operation
Solution Approach 2:
The patent replaces manual operation considerations with optimized chemical parameters that are inherently compatible with automated systems, allowing mechanical/automated liquid delivery without the crystal precipitation problem that would otherwise limit automation feasibility
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method achieves higher reaction conversion rates and prevents crystal precipitation, enabling efficient and automated synthesis of high-purity peptides using both membrane and polymer resin as stationary phases.
Implementation Method 1
a condensation step of condensing the first amino acid or first peptide, and a second amino acid having a protected amino group and/or protected hydroxy group and a carboxy group, or a second peptide having a protected amino group and/or protected hydroxy group and a carboxy group in the presence of at least one carbodiimide-based condensing agent
Data Source
AI summary
A method for producing a peptide compound by a solid phase method, the method comprising:a preparation step of preparing a first amino acid having an amino group or a first peptide having an amino group supported on a solid phase; anda condensation step of condensing the first amino acid or first peptide, and a second amino acid having a protected amino group and/or protected hydroxy group and a carboxy group, or a second peptide having a protected amino group and/orprotected hydroxy group and a carboxy group in the presence of a predetermined carbodiimide-based condensing agent and an additive.


